CASI Pharmaceuticals (CASI) P/E (2020 - 2026)
CASI Pharmaceuticals (CASI) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM CASI Pharmaceuticals (CASI) P/E is -0.09. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of CASI Pharmaceuticals (CASI)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.09 | -75.59% |
| 2025 | -0.36 | -67.45% |
| 2024 | -1.12 | -52.47% |
| 2023 | -2.35 | +244.13% |
| 2022 | -0.68 | -77.63% |
| 2021 | -3.05 | -54.78% |
| 2020 | -6.75 | N/A |
Comparison CASI Pharmaceuticals (CASI) P/E with competitors
CASI Pharmaceuticals (CASI) P/E is -0.09.